From: Evaluation of protein biomarkers of prostate cancer aggressiveness
 | N | Univariate | Multivariate* | ||
---|---|---|---|---|---|
Variable | Â | HR (95% CI) | P-value | HR (95% CI) | P-value |
ACPP | 139 | 0.93 (0.63-1.39) | 0.735 | 1.07 (0.59-1.93) | 0.827 |
ADAM9 | 152 | 0.98 (0.63-1.54) | 0.944 | 1.19 (0.75-1.91) | 0.462 |
ALDH1A2 | 141 | 0.79 (0.47-1.32) | 0.368 | 1.10 (0.62-1.95) | 0.737 |
CASR | 143 | 1.01 (0.65-1.57) | 0.949 | 0.98 (0.58-1.66) | 0.937 |
CCND1 (nuclear) | 142 | 1.38 (1.01-1.88) | 0.042 | 1.18 (0.87-1.61) | 0.296 |
CCPG1 | 143 | 1.19 (0.76-1.88) | 0.446 | 1.14 (0.69-1.86) | 0.611 |
CD34 (avg vess area) | 146 | 1.16 (0.74-1.83) | 0.515 | 1.02 (0.60-1.74) | 0.938 |
CD34 (avg vess per) | 146 | 1.42 (0.91-2.21) | 0.123 | 1.43 (0.84-2.43) | 0.188 |
CD34 (avg lum area) | 146 | 1.45 (0.95-2.22) | 0.086 | 1.37 (0.83-2.27) | 0.220 |
CD34 (avg vasc area) | 146 | 1.02 (0.66-1.60) | 0.915 | 0.89 (0.52-1.53) | 0.682 |
CD34 (MVD) | 146 | 1.11 (0.71-1.73) | 0.652 | 0.97 (0.56-1.67) | 0.901 |
CD34 | 146 | 1.11 (0.72-1.71) | 0.648 | 1.04 (0.63-1.71) | 0.881 |
CD44 | 148 | 1.07 (0.68-1.68) | 0.764 | 1.06 (0.70-1.60) | 0.786 |
CD44v6 | 143 | 1.23 (0.79-1.89) | 0.360 | 1.35 (0.84-2.16) | 0.217 |
CHGA | 136 | 0.50 (0.24-1.04) | 0.064 | 0.56 (0.26-1.21) | 0.139 |
CHMP1A | 146 | 1.31 (0.83-2.08) | 0.244 | 1.35 (0.84-2.20) | 0.218 |
EI24 (stroma) | 140 | 1.24 (0.85-1.82) | 0.265 | 1.36 (0.97-1.91) | 0.077 |
EI24 (tumor) | 140 | 1.32 (0.94-1.87) | 0.114 | 1.32 (0.97-1.79) | 0.077 |
ENO2 | 145 | 1.33 (0.92-1.93) | 0.135 | 1.48 (0.92-2.38) | 0.108 |
GADD45B | 148 | 1.11 (0.72-1.73) | 0.630 | 1.18 (0.78-1.77) | 0.435 |
HA (stroma) | 150 | 1.51 (0.99-2.29) | 0.055 | 1.43 (0.95-2.17) | 0.090 |
HAS2 | 148 | 1.27 (0.82-1.97) | 0.287 | 1.47 (0.94-2.30) | 0.090 |
HES6 | 140 | 0.80 (0.48-1.34) | 0.401 | 0.69 (0.38-1.27) | 0.238 |
HMMR | 139 | 2.01 (1.23-3.30) | 0.005 | 1.98 (1.20-3.29) | 0.008 |
HOXC6 | 142 | 1.22 (0.79-1.89) | 0.368 | 1.51 (1.00-2.28) | 0.050 |
HYAL1 | 147 | 1.42 (0.92-2.21) | 0.116 | 1.40 (0.87-2.25) | 0.163 |
IGF1 | 147 | 1.57 (1.02-2.42) | 0.039 | 1.67 (1.10-2.52) | 0.015 |
IQCK | 149 | 0.90 (0.58-1.40) | 0.651 | 0.90 (0.59-1.38) | 0.625 |
MAP4K4 | 145 | 1.44 (0.91-2.28) | 0.121 | 1.76 (1.08-2.86) | 0.024 |
MKI67 (nuclear) | 142 | 1.43 (1.04-1.96) | 0.026 | 1.29 (0.93-1.79) | 0.125 |
PAGE4 | 145 | 0.68 (0.45-1.03) | 0.069 | 0.88 (0.57-1.35) | 0.566 |
PLIN2 | 115 | 1.21 (0.71-2.09) | 0.481 | 1.07 (0.62-1.86) | 0.801 |
PTEN | 144 | 0.83 (0.54-1.27) | 0.393 | 0.84 (0.51-1.38) | 0.493 |
SIAH2 (nuclear) | 144 | 1.46 (1.07-1.99) | 0.016 | 1.37 (0.94-2.02) | 0.104 |
SMAD4 | 130 | 1.76 (1.15-2.71) | 0.010 | 1.73 (1.11-2.70) | 0.016 |
SOX9 | 145 | 1.39 (0.90-2.16) | 0.137 | 1.45 (0.93-2.27) | 0.101 |
SPP1 | 128 | 1.07 (0.62-1.84) | 0.805 | 0.76 (0.44-1.33) | 0.338 |
SYP | 133 | 0.88 (0.48-1.63) | 0.681 | 0.95 (0.53-1.70) | 0.869 |
TP53_Lab1 (nuclear) | 148 | 1.23 (0.83-1.83) | 0.305 | 1.19 (0.78-1.82) | 0.431 |
TP53_Lab2 (nuclear) | 143 | 0.97 (0.63-1.50) | 0.906 | 0.93 (0.60-1.44) | 0.741 |